New Study Enhances Alzheimer's Diagnosis: PET Scan vs. Spinal Tap

**Researchers at LMU University Hospital** have provided insights crucial for enhancing *Alzheimer’s diagnosis* through a recent study comparing cerebrospinal fluid (CSF) analysis and positron emission tomography (PET) imaging. With new drugs targeting amyloid plaques approved in Europe, precise diagnostic methods are vital. **CSF analysis**, though widely utilized, involves invasive spinal taps and yields indirect results, while **PET imaging** offers a non-invasive, direct assessment but remains costly and less accessible. Data from over 400 patients at LMU Hospital revealed that CSF amyloid values below 5.5 often correlated with Alzheimer’s-positive PET scans, whereas values above 7.1 mostly did not. A notable gray area between 5.5 and 7.1 highlighted inconsistencies, suggesting unreliability in CSF alone. These findings were validated by an independent cohort in Vienna. _The study indicates that with broader access to affordable PET imaging, reliance on CSF could decrease, streamlining diagnostic procedures._ Until then, CSF remains the initial choice, except for specific medical conditions necessitating PET. This research sets the stage for improved clinical practices as treatments evolve.